GlobalData on MSN10h
Sanofi’s Sarclisa combo approved in China for multiple myeloma
Sanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...
Here is a select list of stories to start the day.
The Centre’s decision to significantly slash the income tax payer’s burden was aimed at addressing some “angst” that the ...